Histologically confirmed epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer
Conditions
Interventions
Observation group:None
Sponsors
The affiliated hospital of southwest medical university
Eligibility
Sex/Gender
Female
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.Aged >=18 years. 2.ECOG PS 0–2. 3.Having indications for bevacizumab use in accordance with routine clinical diagnosis and treatment. 4.For subjects who have previously received treatment consistent with this protocol, comprehensive pre-treatment assessments shall be available, including demographics, tumor history, past medical history, and baseline imaging examinations. 5.Signed the informed consent form and voluntarily participated in this study.
Exclusion criteria
Exclusion criteria: 1.Presence of any contraindications to bevacizumab. 2.Confirmed pregnant or lactating women. 3.Other conditions that the investigator deems inappropriate for study inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety; | — |
Secondary
| Measure | Time frame |
|---|---|
| DOT;DCR;ORR;PFS; | — |
Countries
China
Contacts
Public ContactLuo lin
The affiliated hospital of southwest medical university
Outcome results
None listed